High levels of catalytic antibodies correlate with favorable outcome in sepsis.
about
Need for a paradigm shift in therapeutic approaches to CNS injuryStrain-specific virulence phenotypes of Streptococcus pneumoniae assessed using the Chinchilla laniger model of otitis mediaImmunological origin and functional properties of catalytic autoantibodies to amyloid beta peptide.IVIg treatment reduces catalytic antibody titers of renal transplanted patientsAutoantibodies with enzymatic properties in human autoimmune diseases.DNA-hydrolysing activity of IgG antibodies from the sera of patients with diseases caused by different bacterial infections.Constitutive production of catalytic antibodies to a Staphylococcus aureus virulence factor and effect of infection.Antibodies to H1 histone from the sera of HIV-infected patients recognize and catalyze site-specific degradation of this histone.Constant domain-regulated antibody catalysis.Identification and Characterization of the Trypanosoma cruzi B-cell Superantigen Tc24Generation of Catalytic Antibodies Is an Intrinsic Property of an Individual's Immune System: A Study on a Large Cohort of Renal Transplant Patients.Affinity and catalytic heterogeneity of polyclonal myelin basic protein-hydrolyzing IgGs from sera of patients with multiple sclerosisFormation of different abzymes in autoimmune-prone MRL-lpr/lpr mice is associated with changes in colony formation of haematopoietic progenitors.Sepsis biomarkers: a review.Do proteolytic antibodies complete the panoply of the autoimmune response in acquired haemophilia A?Antibody-antigen pair probed by combinatorial approach and rational design: bringing together structural insights, directed evolution, and novel functionality.B-cell-mediated strategies to fight chronic allograft rejectionIL-10-independent regulatory B-cell subsets and mechanisms of action.Selective Photocatalytic Disinfection by Coupling StrepMiniSog to the Antibody Catalyzed Water Oxidation Pathway.Antibody-Mediated Catalysis in Infection and Immunity.Antibodies to H2a and H2b histones from the sera of HIV-infected patients catalyze site-specific degradation of these histones.A human germ line antibody light chain with hydrolytic properties associated with multimerization status.Generation, characterization, and docking studies of DNA-hydrolyzing recombinant F(ab) antibodies.A metalloantibody that irreversibly binds a protein antigen.Hydrolysis of factor VIII mediated by catalytic antibodies occurs in haemophilia A patients with or without factor VIII inhibitors.Factor VIII-hydrolyzing IgG in acquired and congenital hemophilia.IgG antibodies with peroxidase-like activity from the sera of healthy Wistar rats.Autoantibody-catalyzed hydrolysis of amyloid beta peptide.Anti-integrase abzymes from the sera of HIV-infected patients specifically hydrolyze integrase but nonspecifically cleave short oligopeptides.Substrate specificity of healthy human sera IgG antibodies with peroxidase and oxydoreductase activities.Affinity and catalytic heterogeneity and metal-dependence of polyclonal myelin basic protein-hydrolyzing IgGs from sera of patients with systemic lupus erythematosus.Diagnostics of autoimmune neurodegeneration using fluorescent probingCatalytic antibodies in patients with systemic lupus erythematosusEmergence of autoantibodies to HMGB1 is associated with survival in patients with septic shockCatalytic antibodies from HIV-infected patients specifically hydrolyzing viral integrase suppress the enzyme catalytic activities
P2860
Q27025042-6514C557-C090-40E5-B00A-65E6FBB7E075Q33327378-A5B24585-E6FD-4AF7-B13E-1C820ADC7A81Q33573668-506B4522-9DD5-48A6-96A0-DAA4DC4FF1ADQ34962680-1D326F1C-E8E4-44C0-9B5B-6C9B81AFAF4EQ35214200-6527D505-ADA5-4D59-AB51-B49638C36FFFQ35841936-63386AE8-9875-40D3-AB5C-FD34597CC0B4Q35880109-4D057413-CB2D-409F-96A3-393DDBDCFCEEQ36197918-140F12B1-75BA-470E-89CB-C7E523D3A8E9Q36332826-A95D8F6D-1254-41F9-8BD2-0DA751F3C5DDQ36455741-AA312146-93A0-4D71-9323-10CD9CD63C85Q36905946-985AF7C6-5844-44FD-A048-8B45E9D656E6Q37296340-0C6DBC3F-3742-4549-9EDF-78465BC8BDB1Q37580191-4AAB48A4-15DB-46E2-AE07-9F54183079A4Q37689825-A9C13B5A-58AB-4AF0-9140-079F0A1A9757Q37944291-76026422-70E9-4E89-97CD-B601689779ECQ38030235-E1060A58-984B-487E-A217-01BFFF494D5BQ38175026-F8549FB3-DF6F-4A1F-A1DE-EBB85BB1A0C1Q38497062-9445E2BC-CD91-4F9F-960A-233C4921EDE2Q39401709-2407BBA5-8E88-4346-B971-748BBFFB5AB4Q39412526-AE0DA7EB-C3FF-461A-A807-78BD45529822Q40234883-B8414BDD-1BD1-4CB3-9D76-099A2250DBDBQ42680119-5ABE82BE-4221-41D9-B47A-6EACBE2C3574Q42798552-D0D46C0A-4669-4BFB-A2E3-30FAC2FE5DC6Q43808918-934AA81B-2A6D-455D-8E0A-B42518D4D3A1Q45883602-014A1E77-C59F-4BA7-87C4-E81E54307DE4Q45886858-31438478-5C24-4A34-AABF-4DA7B46F7AD5Q46580184-1E99178E-2391-48C7-BA2F-137F5B2AE989Q46845401-F10BB21E-208F-4D3A-8EE6-C8BEA7DCA677Q47998913-E69AE807-FBB7-4FAC-B48F-EB2C120D4101Q48094602-A4FEE340-5D6C-4104-A596-9E4CB4C9B7B5Q53209420-12A99324-B634-448A-9238-D5B8F112941CQ58714753-A5CF6EAD-AF84-4E14-AF3B-618B80F4B742Q58796857-2AB14EF6-EF27-4ED7-BBA5-B01205806FA4Q58861244-0CC8D544-470A-4C09-81B8-150114677EE8Q59084568-477024AB-2ECA-437E-9CBC-95779251FB38
P2860
High levels of catalytic antibodies correlate with favorable outcome in sepsis.
description
2005 nî lūn-bûn
@nan
2005 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի մարտին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
High levels of catalytic antibodies correlate with favorable outcome in sepsis.
@ast
High levels of catalytic antibodies correlate with favorable outcome in sepsis.
@en
type
label
High levels of catalytic antibodies correlate with favorable outcome in sepsis.
@ast
High levels of catalytic antibodies correlate with favorable outcome in sepsis.
@en
prefLabel
High levels of catalytic antibodies correlate with favorable outcome in sepsis.
@ast
High levels of catalytic antibodies correlate with favorable outcome in sepsis.
@en
P2093
P2860
P50
P356
P1476
High levels of catalytic antibodies correlate with favorable outcome in sepsis
@en
P2093
Charles-Edouard Luyt
David Hayon-Sonsino
Jean-François Dhainaut
Jean-Paul Mira
Julien Charpentier
Michel D Kazatchkine
Nithyananda Thorenoor
Srini V Kaveri
Valakunja Nagaraja
P2860
P304
P356
10.1073/PNAS.0500586102
P407
P577
2005-03-02T00:00:00Z